Abstract
Forty-five colorectal adenocarcinomas were examined for alterations in the HIT family genes FHIT and PKCI-1/HINT by a combination of reverse transcriptase polymerase chain reaction and DNA sequencing. In all cases a single transcript corresponding to the reported sequence was detected using primers specific for the PKCI-1/HINT gene. In contrast multiple transcripts were detected using primers specific for the FHIT gene transcript. 6% (3/45) of tumours evinced no detectable expression of any FHIT transcript and a further 12% (6/45) produced only the normal full length transcripts. Ninety-six aberrant transcripts were characterized from the remaining tumours. Deviations from the normal full length sequence characterized included deletions, insertions of novel sequences, a point mutation as well as the usage of a putative alternate splice site in exon 10. Message variants were detected with approximately equal frequency in all tumour stages with the exception that templates with insertions were found solely in Dukes’ stage B tumours (P < 0.001). With the exception of the putative alternate splice site, aberrant transcripts were not detected in matched normal mucosa. These results suggest that members of the HIT family of genes are only selectively involved in tumorigenesis and that perturbation of FHIT gene expression is an early event in colorectal tumorigenesis.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Abderrahim, H, Cohen, D, Leppert, M & White, R (1991) Identification and characterisation of the familial adenomatous polyposis coli gene. Cell 66: 589–600.
Ahmadian, M, Wistuba, II, Fong, KM, Behrens, C, Kodagoda, DR, Saboorian, MH, Shay, J, Tomlinson, GE, Blum, J, Minna, JD & Gazdar, AF (1997) Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Cancer Res 57: 3664–3668.
Baker, SJ, Fearon, ER, Nigro, JM, Hamilton, SR, Preisinger, AC, Jessup, JM, vanTuinen, P, Ledbetter, DH, Barker, DF, Nakamura, Y, White, R & Vogelstein, B (1989) Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244: 217–221.
Bos, JL, Fearon, ER, Hamilton, SR, Verlaan-de Vries, M, van Boom, JH, van der Eb, AJ & Vogelstein, B (1987) Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293–297.
Bronner, CE, Baker, SM, Morrison, PT, Warren, G, Smith, LG, Lescoe, MK, Kane, M, Earabino, C, Lipford, J, Lindblom, A, Tannergard, P, Bollag, RJ, Godwin, AR, Ward, DC, Nordenskjold, M, Fishel, R, Kolodner, R & Liskay, RM (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368: 258–261.
Brzoska, PM, Chen, H, Zhu, Y, Levin, NA, Disatnik, MH, Mochly-Rosen, D, Murnan, JP & Christman, MF (1995) The product of the ataxia-telangiectasia group D complementing gene, ATDC, interacts with a protein kinase C substrate and inhibitor. Proc Natl Acad Sci USA 92: 7824–7828.
Chen, YJ, Chen, PH, Lee, MD & Chang, JG (1997) Aberrant FHIT transcripts in cancerous and corresponding non-cancerous lesions of the digestive tract. Int J Cancer 72: 955–958.
Chew, LJ, Murphy, D & Carter, DA (1994) Alternatively polyadenylated vasoactive intestinal peptide mRNAs are differentially regulated at the level of stability. Mol Endocrinol 8: 603–613.
Cohen, AJ, Li, FP, Berg, S, Marchetto, DJ, Tsai, S, Jacobs, SC & Brown, RS (1979) Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med 301: 592–595.
Dukes, CE (1932) The classification of cancer of the rectum. J Pathol Bacteriol 35: 323–332.
Erisman, MD, Rothberg, PG, Diehl, RE, Morse, CC, Spandorfer, JM & Astrin, SM (1985) Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene. Mol Cell Biol 5: 1969–1976.
Fearon, ER & Vogelstein, B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759–767.
Fishel, R, Lescoe, MK, Rao, MR, Copeland, NG, Jenkins, NA, Garber, J, Kane, M & Kolodner, R (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75: 1027–1038.
Fong, KM, Biesterveld, EJ, Virmani, A, Wistuba, I, Sekido, Y, Bader, SA, Ahmadian, M, Ong, ST, Rassool, FV, Zimmerman, PV, Giaccone, G, Gazdar, AF & Minna, JD (1997) FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res 57: 2256–2267.
Gemma, A, Hagiwara, K, Ke, Y, Burke, LM, Khan, MA, Nagashima, M, Bennett, WP & Harris, CC (1997) FHIT mutations in human primary gastric cancer. Cancer Res 57: 1435–1437.
Greenspan, DL, Connolly, DC, Wu, R, Lei, RY, Vogelstein, JT, Kim, YT, Mok, JE, Munoz, N, Bosch, FX, Shah, K & Cho, KR (1997) Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res 57: 4692–4698.
Groden, J, Thliveris, A, Samowitz, W, Carlson, M, Gelbert, L, Albertsen, H, Joslyn, G, Stevens, J, Spirio, L, Robertson, M, Sargeant, L, Krapcho, K, Wolff, E, Burt, R, Hughes, JP, Warrington, J, McPherson, J, Wasmuth, J, Le Paslier, D, Hendricks, DT, Taylor, R, Reed, M & Birrer, MJ (1997) FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Cancer Res 57: 2112–2115.
Huang, Y, Garrison, PN & Barnes, L (1995) Cloning of the Schizosaccharomyces pombe gene encoding diadenosine 5′,5′′′-P1,P4-tetraphosphate (Ap4A) asymmetrical hydrolase: sequence similarity with the histidine triad (HIT) protein family. Biochem J 312: 925–932.
Huebner, K, Garrison, PN, Barnes, LD & Croce, CM (1998) The role of the FHIT/FRAB3B locus in cancer. Ann Rev Genet 32: 7–31.
Kapp, LN, Painter, RB, Yu, LC, van Loon, N, Richard, CW, James, MR, Cox, DR & Murnane, JP (1992) Cloning of a candidate gene for ataxia-telangiectasia group D. Am J Hum Genet 51: 45–54.
Kozak, M (1984) Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res 12: 857–872.
Knudson, AG (1985) Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45: 1437–1443.
Lima, CD, Klein, MG, Weinstein, IB & Hendrickson, WA (1996) Three-dimensional structure of human protein kinase C interacting protein 1, a member of the HIT family of proteins. Proc Natl Acad Sci USA 93: 5357–5362.
Lima, CD, D’Amico, KL, Naday, I, Rosenbaum, G, Westbrook, EM & Hendrickson, WA (1997) MAD analysis of FHIT, a putative human tumour suppressor from the HIT protein family. Structure 5: 763–764.
Mao, L, Fan, YH, Lotan, R & Hong, WK (19???) Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res 56: 5128–5131.
Michael, D, Beer, DG, Wilke, CW, Miller, DE & Glover, TW (1997) Frequent deletions of FHIT and FRA3B in Barrett’s metaplasia and esophageal adenocarcinomas. Oncogene 15: 1653–1659.
Murphree, AL & Benedict, WF (1984) Retinoblastoma: clues to human oncogenesis. Science 223: 1028–1033.
Negrini, M, Monaco, C, Vorechovsky, I, Ohta, M, Druck, T, Baffa, R, Huebner, K & Croce, CM (19???) The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res 56: 3173–3179.
Ohta, M, Inoue, H, Cotticelli, MG, Kastury, K, Baffa, R, Palazzo, J, Siprashvili, Z, Mori, M, McCue, P, Druck, T, Croce, CM & Huebner, K (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587–597.
Pearson, JD, DeWald, DB, Mathews, WR, Mozier, NM, Zurcher-Neely, HA, Heinrikson, RL, Morris, MA, McCubbin, WD, McDonald, JR, Fraser, ED, Vogel, HJ, Kay, MC & Walsh, MP (1990) Amino acid sequence and characterization of a protein inhibitor of protein kinase C. J Biol Chem 265: 4583–4591.
Russell, JE, Morales, J, Makeyev, AV & Liebhaber, SA (1998) Sequence divergence in the 3′ untranslated regions of human zeta- and alpha-globin mRNAs mediates a difference in their stabilities and contributes to efficient alpha-to-zeta gene development switching. Mol Cell Biol 18: 2173–2183.
Simon, B, Bartsch, D, Barth, P, Prasnikar, N, Munch, K, Blum, A, Arnold, R & Goke, B (1998) Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines. Cancer Res 58: 1583–1587.
Siprashvili, Z, Sozzi, G, Barnes, LD, McCue, P, Robinson, AK, Eryomin, V, Sard, L, Tagliabue, E, Greco, A, Fusetti, L, Schwartz, G, Pierotti, MA, Croce, CM & Huebner, K (1997) Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA 94: 13771–13776.
Sozzi, G, Veronese, ML, Negrini, M, Baffa, R, Cotticelli, MG, Inoue, H, Tornielli, S, Pilotti, S, De Gregorio, L, Pastorino, U, Pierotti, MA, Ohta, M, Huebner, K & Croce, CM (1996a) The FHIT gene 3p14.2 is abnormal in lung cancer. Cell 85: 17–26.
Sozzi, G, Alder, H, Tornielli, S, Corletto, V, Baffa, R, Veronese, ML, Negrini, M, Pilotti, S, Pierotti, MA, Huebner, K & Croce, CM (1996b) Aberrant FHIT transcripts in Merkel cell carcinoma. Cancer Res 56: 2472–2474.
Su, TH, Wang, JC, Tseng, HH, Chang, CP, Chang, TA, Wei, HJ & Chang, JG (1998) Analysis of FHIT transcripts in cervical and endometrial cancers. Int J Cancer 76: 216–222.
Thiagalingam, S, Lisitsyn, NA, Hamaguchi, M, Wigler, MH, Willson, JK, Markowitz, SD, Leach, FS, Kinzler, KW & Vogelstein, B (1996) Evaluation of the FHIT gene in colorectal cancers. Cancer Res 56: 2936–2939.
Turnbull, RB, Kyle, K, Watson, FR & Spratt, J (1967) Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg 166: 420–427.
Wang, N & Perkins, KL (1984) Involvement of band 3p14 in t(3;8) hereditary renal carcinoma. Cancer Genet Cytogenet 11: 479–481.
Zehner, ZE, Shepherd, RK, Gabryszuk, J, Fu, TF, Al-Ali, M & Holmes, WM (1997) RNA–protein interactions within the 3′ untranslated region of vimentin mRNA. Nucleic Acids Res 25: 3362–3370.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Elnatan, J., Murphy, D., Goh, HS. et al. HIT family genes: FHIT but not PKCI-1/HINT produces altered transcripts in colorectal cancer. Br J Cancer 81, 874–880 (1999). https://doi.org/10.1038/sj.bjc.6690779
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690779